{
    "id": 277,
    "title": "Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response",
    "short_name": "Impaired IL-1R1 signaling leading to impairment of TDAR",
    "created_at": "2018-12-20T20:02:52.000-05:00",
    "updated_at": "2023-08-28T08:41:37.000-04:00",
    "corresponding_author": {
        "id": 883,
        "created_at": "2019-05-30T00:58:21.000-04:00",
        "updated_at": "2023-12-06T23:46:24.000-05:00",
        "subscribed": true,
        "novice": true
    },
    "aop_stressors": [
        {
            "stressor_id": 489,
            "stressor_name": "IL-1 receptor antagonist\uff08IL-1Ra\uff09(Anakinra)"
        },
        {
            "stressor_id": 490,
            "stressor_name": "anti-IL-1b antibody (Canakinumab)"
        },
        {
            "stressor_id": 491,
            "stressor_name": "soluble IL-1R (Rilonacept)"
        },
        {
            "stressor_id": 518,
            "stressor_name": "anti-IL-1b antibody (Gevokizumab)"
        },
        {
            "stressor_id": 492,
            "stressor_name": "Dexamethasone"
        },
        {
            "stressor_id": 486,
            "stressor_name": "minocycline"
        },
        {
            "stressor_id": 609,
            "stressor_name": "Belnacasan (VX-765)"
        },
        {
            "stressor_id": 611,
            "stressor_name": "Pralnacasan (VX-740, HMR3480)"
        },
        {
            "stressor_id": 488,
            "stressor_name": "cinnamic aldehyde"
        },
        {
            "stressor_id": 637,
            "stressor_name": "Dimethyl fumarate"
        },
        {
            "stressor_id": 612,
            "stressor_name": "curcumin"
        },
        {
            "stressor_id": 614,
            "stressor_name": "iguratimod"
        },
        {
            "stressor_id": 638,
            "stressor_name": "(-)-Epigallocatechin gallate"
        },
        {
            "stressor_id": 616,
            "stressor_name": "TAK-242"
        },
        {
            "stressor_id": 617,
            "stressor_name": "IRAK4 inhibitors"
        },
        {
            "stressor_id": 636,
            "stressor_name": "Dehydroxymethylepoxyquinomicin (DHMEQ)"
        }
    ],
    "aop_mies": [
        {
            "event_id": 1700,
            "event": "Impaired IL-1R1 signaling in T cell",
            "event_type": "MolecularInitiatingEvent"
        }
    ],
    "aop_kes": [
        {
            "event_id": 202,
            "event": "Inhibition, Nuclear factor kappa B (NF-kB)",
            "event_type": "KeyEvent"
        },
        {
            "event_id": 1702,
            "event": "Suppression of  T cell activation",
            "event_type": "KeyEvent"
        }
    ],
    "aop_aos": [
        {
            "event_id": 984,
            "event": "Impairment, T-cell dependent antibody response",
            "event_type": "AdverseOutcome"
        }
    ],
    "relationships": [
        {
            "relation": 2024,
            "upstream_event_id": 1700,
            "upstream_event": "Impaired IL-1R1 signaling in T cell",
            "downstream_event_id": 202,
            "downstream_event": "Inhibition, Nuclear factor kappa B (NF-kB)"
        },
        {
            "relation": 2025,
            "upstream_event_id": 202,
            "upstream_event": "Inhibition, Nuclear factor kappa B (NF-kB)",
            "downstream_event_id": 1702,
            "downstream_event": "Suppression of  T cell activation"
        },
        {
            "relation": 3476,
            "upstream_event_id": 1702,
            "upstream_event": "Suppression of  T cell activation",
            "downstream_event_id": 984,
            "downstream_event": "Impairment, T-cell dependent antibody response"
        }
    ]
}